Modern approaches to the prevention of pneumococcal infection
https://doi.org/10.21518/2079-701X-2015-16-64-67
Abstract
Pneumococcal diseases are widespread all over the world. According to WHO, every year14.5 million (11,1--18 million) of children under the age of 5 years suffer from the diseases, while the number of deaths due to pneumococcal infection reaches 826 thousand (582--926 thousand), or 11% of all deaths among children in this age group. At the same time, pneumococci may be part of the normal flora of the upper respiratory tract contributing to the bacteria carrying capacity. The carrying may be asymptomatic but may result in contact or hematogenous penetration of microorganisms from nasopharynx to other organs. This is largely determined by the pneumococcal serotype.
About the Authors
S. M. Kharit
Research Institute of Children's Infections of the Federal Medical and Biological Agency, Saint-Petersburg
Russian Federation
Russian Federation
A. L. Perova
Research Institute of Children's Infections of the Federal Medical and Biological Agency, Saint-Petersburg
Russian Federation
Russian Federation
References
1. PLotkin SA, Orenstein W, Offit PA. Vaccines, 6th Edition. ELsevier Inc., 2013.
2. European Centre for Disease Prevention and Control. Surveillance of invasive pneumococcal disease in Europe, 2010. Stockholm: ECDC, 2012.
3. Pneumococcal vaccines WHO position paper -2012 6 apriL 2012, 87th year, 14, 2012, 87, 129-144, http//www.who.int/wer.
4. Баранов А.А., Таточенко В.К., Намазова Л.С. Нужно ли защищать детей от пневмококковой инфекции? Вопросы современной педиатрии, 2008, 7, 1: 13-16.
5. KoroLeva IS, BeLoshitskiy GV. Epidemiological characteristics of pneumococcaL meningitis in chiLdren aged under 6 years of age in the Russian Federation. Epidemiol. Infect. Dis. Comprehensive iss. 2012, 1: 18-21.
6. Вакцины и вакцинация: Национальное руководство. Под ред. В.В. Зверева, Б.Ф. Семенова, Р.М. Хаитова. М.: ГЭОТАР-Медиа, 2011: 872.
7. Griffin R, Zhu Y, Moore MR, Whitney CG, GrijaLva US. HospitaLizations for Pneumonia after a Decade of PneumococcaL Vaccination. N. engl j med, 2013, 369, 2 nejm.org juLy 11: 155-163.
8. Marom T, Tan A, WiLkinson GS, Pierson KS, Freeman JL, Chonmaitree T. Trends in Otitis Media-reLated HeaLth Care UtiLization in the United States, 2001-2011. JAMA Pediatr. 2014 January, 168(1): 68-75.
9. Richardsona A, Morrisa DE, CLarkea SC. Vaccination in Southeast Asia-Reducing meningitis, sepsis and pneumonia with new and existing vaccines. Vaccine 32 (2014): 4119-4123.
10. Pнrez MC, ALgorta G, Chamorro F et aL. Changes in HospitaLizations for Pneumonia After UniversaL Vaccination With PneumococcaL Conjugate Vaccines 7/13 VaLent and HaemophiLus infLuenzae Type b Conjugate Vaccine in a Pediatric ReferraL HospitaL in Uruguay. Pediatr Infect Dis J 2014, 33: 753-759.
11. Черная Н.Л., Дадаева О.Б., Шубина Е.В. [и др.]. Эффективность вакцинопрофилактики пневмококковой инфекции у детей с применением пневмококковой конъюгированной 7-валентной вакцины. Педиатрическая фармакология, 2013. 10 (1): 7-12.
12. Weinberger DM, Ri. MaLLey M. Lipsitch Serotype repLacement in disease after pneumococcaL Vaccination. /www.theLancet.com/ 2011, 378 December 3: 1962-1973.
13. Moore CG. Whitney Use of PneumococcaL Disease EpidemioLogy to Set PoLicy and Prevent Disease during 20 Years of the Emerging Infections Program Emerging Infectious Diseases • www, cdc.gov/eid, 21, 9, September 2015: 1551-1556.
14. Лобзин Ю.В., Сидоренко С.В., Харит С.М. [и др.]. Серотипы Streptococcus pneumoniae, вызывающих ведущие нозологические формы пневмококковых инфекций. Ж. инфектологии. 2013. 5. 4: 36-42.
15. Tatochenko V, Sidorenko S, Namazova-Baranova L et aL. Streptococcus pneumoniae serotype distribution in chiLdren in the Russian Federation before the introduction of pneumococcaL conjugate vaccines into the NationaL Immunization Program Expert Rev. Vaccines, 2014, 13(2): 257-264.
16. Sobanjo-ter MeuLen A, Vesikari T, MaLacaman EA et aL. Safety, ToLerabiLity and Immunogenicity of 15-vaLent PneumococcaL Conjugate Vaccine in ToddLers PreviousLy Vaccinated With 7-vaLent PneumococcaL Conjugate Vaccine. Pediatr Infect Dis J., 2015, 34(2): 186-194.
Review
For citations:
Kharit SM, Perova AL. Modern approaches to the prevention of pneumococcal infection. Meditsinskiy sovet = Medical Council. 2015;(16):64-67. (In Russ.) https://doi.org/10.21518/2079-701X-2015-16-64-67
Views:
433
Email this article 